Sarah Wall, MD, talks about how it’s important to consider patient age when treating older patients with cancer because it will impact so many of them and blood cancers act differently and can be more aggressive in older adults.
With the population of older adults growing, it is becoming more important for providers to put attention on older adults, who are more likely to be diagnosed with cancer and in whom blood-based cancers function differently and more aggressively, explains Sarah Wall, MD, assistant professor in the Division of Hematology at The Ohio State University.
Transcript
Why is it important to study the relationship between age and hematological diseases and hematological cancers?
It's a really important question because it affects so many people, and I think that's the easy answer. In the US, the average age of the population is continuing to rise. The estimates are that by 2030, more than two-thirds of the population will be above the age of 60. Along with that, we would expect about 70% of those older adults to be diagnosed with a cancer because cancers are often diagnosed in older people related to changes that occur with age.
For blood cancers, in particular, it's also an important question because a lot of blood cancers behave differently in older adults. In acute myeloid leukemia, for example, there has been research looking at the differences in disease genetic markers, between patients younger than 60 and older than 60. Patients who are older than 60 with the same mutations as the younger group will behave differently and often will have more aggressive disease features. These are important things to take into consideration when you're treating these patients, that even though they may look the same by mutational status, the age may make a difference.
Managed Care Reflections: A Q&A With Hoangmai H. Pham, MD, MPH
April 1st 2025To mark the 30th anniversary of The American Journal of Managed Care® (AJMC®), each issue in 2025 will include a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The April issue features a conversation with Hoangmai H. Pham, MD, MPH, a member of AJMC’s editorial board and the president and CEO of the Institute for Exceptional Care (IEC).
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Bridging Care Gaps With a Systemwide Value-Based Care Strategy
March 29th 2025Mapping care management needs by defining patient populations and then stratifying them according to risk and their needs can help to spur the transformation of a siloed health care system into an integrated system that is able to better provide holistic, value-based care despite the many transitions that continue among hospital, primary, specialty, and community care environments.
Read More
Dermatologists Advocating for Inclusive Hair Loss Research and Treatment in the African Diaspora
March 26th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, advocates for increased funding and education to address hair loss disparities within the African diaspora, emphasizing the need for culturally sensitive treatment and research.
Read More